Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Patanjali Foods Announces Interim Dividend and Strong Quarterly Financial Results

Consumer Products

|

Updated on 08 Nov 2025, 08:59 am

Whalesbook Logo

Reviewed By

Abhay Singh | Whalesbook News Team

Short Description:

Patanjali Foods Limited's board has approved an interim dividend of ₹1.75 per equity share for the financial year 2025-26, with a record date set for November 13, 2025, and payment expected by December 7, 2025. The company also reported a significant 67.4% year-on-year increase in net profit to ₹517 crore, and its revenue from operations grew by 21% to ₹9,344.9 crore for the quarter.
Patanjali Foods Announces Interim Dividend and Strong Quarterly Financial Results

▶

Stocks Mentioned:

Patanjali Foods Limited

Detailed Coverage:

Patanjali Foods Limited announced on November 8, 2025, that its board has sanctioned an interim dividend of ₹1.75 per equity share for the financial year 2025-26. This dividend, based on equity shares with a face value of ₹2 each, is scheduled to be disbursed on or before December 7, 2025. To determine the eligible shareholders for this payout, the board fixed November 13, 2025, as the record date.

In addition to the dividend, the company revealed robust financial performance for the quarter. Its net profit saw a substantial rise of 67.4%, reaching ₹517 crore. Revenue from operations also experienced healthy growth, increasing by 21% year-on-year to ₹9,344.9 crore. The company's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 19.4%, with the EBITDA margin reported at 5.6%.

Impact This news is positive for Patanjali Foods Limited investors. The declaration of an interim dividend directly benefits shareholders by distributing profits. Furthermore, the strong quarterly financial results, marked by significant profit and revenue growth, are likely to boost investor confidence and potentially lead to an appreciation in the company's stock price. Impact Rating: 7/10

Difficult Terms Explained:

Interim dividend: A dividend paid out to shareholders by a company that is in addition to any final dividend that may be declared later at the company's annual general meeting.

Equity share: A type of security that signifies ownership in a corporation and represents claims on part of the corporation's assets and earnings.

Face value: The nominal value or dollar value of a security stated by the issuer. For stocks, it is the portion of the value of the issued capital that is represented by a single share.

Record date: A date set by a company to determine which shareholders are eligible to receive a dividend or vote on corporate matters.

Revenue from operations: The income generated by a company from its core business activities, such as selling goods or providing services, before deducting any expenses.

EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure of a company's overall financial performance and is used as an alternative to net income.

EBITDA margin: A profitability ratio calculated as EBITDA divided by revenue. It indicates the profitability of a company's core business operations.


Healthcare/Biotech Sector

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns


Brokerage Reports Sector

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors